Press Releases

---

Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale

Patient Access to Trudhesa® to Continue Uninterrupted Sufficient Liquidity to Fund Day to Day Operations During Court-Supervised Process SEATTLE ,…

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL) (“Impel” or “the Company”), a commercial-stage biopharmaceutical company…

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

Real-World Assessment Suggests that Concomitant Preventive and Acute Medication Use Decreases in Patients Using Trudhesa Additional Poster Underscores the Need…

Events

---

2022 AAN Annual Meeting

2022 HCOP Winter Conference

2021 International Headache Congress

2021 PAINWeek Conference